While COVID-19 cases decline across the U.S., hospitals report growing concerns about a rare inflammatory condition affecting children previously infected with the virus. Multisystem Inflammatory Syndrome in Children (MIS-C) has emerged as a post-viral threat, with symptoms including organ inflammation, persistent fever, and cardiac complications.
The CDC confirms over 9,000 MIS-C cases nationally since 2020, with recent clusters reported in Texas and Florida. Though representing less than 0.1% of pediatric COVID-19 cases, the syndrome's unpredictability alarms doctors. 'We're seeing delayed reactions – children who seemed fine during initial infections developing severe symptoms weeks later,' explains Dr. Alicia Smith, a pediatric infectious disease specialist at Boston Children's Hospital.
Researchers emphasize vaccination reduces MIS-C risks while urging parents to monitor for symptoms like rash, bloodshot eyes, or abdominal pain. Global health networks are sharing treatment protocols as similar patterns emerge in Europe and South America.
Reference(s):
cgtn.com
